Faculty

Denise M. Boudreau

Affiliate Professor, Epidemiology
Affiliate Professor, Pharmacy

206-287-2067

Education

PhD Pharmacoepidemiology, University of Washington, 2002
MS Pharmacy Administration, University of Rhode Island, 1996
BS Pharmacy, University of Rhode Island, 1992

Contact

206-287-2067

1730 Minor Ave, Suite 1600
Seattle, WA 98101

Bio

Dr. Boudreau is a Senior Investigator at the Group Health Research Institute as well as an affiliate faculty member in both the Department of Epidemiology and Pharmacy at the University of Washington. She is involved in a wide array of pharmacoepidemiology and pharmacoeconomic research projects at Group Health and across the HMO Research Network (HMORN). She has extensive experience working with automated health plan data and bring expertise in the areas of observational study design/comparative effectiveness, managed care, drug safety, and economic evaluation. She has been the HMORN Steering Committee Representative on the FDA Mini Sentinel Initiative since 2009. Her main research interests include cancer pharmacoepidemiology, opioid safety, bone health, and cost of cancer.

Research Areas

Research Interests

Pharmacoepidemiology and pharmacoeconomics

Recent Publications (PubMed)

Neural tube defect risk in relation to opioid analgesic exposure during early pregnancy.
(2025 Apr 22)
Am J Epidemiol
Boudreau DM, Pocobelli G, Bobb JF, Cheetham C, Dublin S, Andrade SE, Albertson-Junkans L, Griffin MR, Li DK, Raebel MA, Hechter RC, Pawloski PA, Toh S, Hua W, Ouellet-Hellstrom R, Horn P, Dinatale M, Ceresa C, Soukup M, Ma Y, Trinidad JP
Use of Real-World Claims Data to Assess the Prevalence of Concomitant Medications to Inform Drug-Drug Interaction Risk in Target Patient Populations.
(2025 Apr 1)
Clin Pharmacol Ther
Tang AS, Brooks L, Boudreau DM, Chanu P, Joshi A, Vora B, Zhu R
Telemedicine Use Before and During the COVID-19 Pandemic in People with Alzheimer's Disease, Multiple Sclerosis, or Parkinson's Disease: A Cross-Sectional Study Using US Commercial Claims Data.
(2024)
Telemed Rep 5(1): 247-255
Patel AM, Schuldt R, Boudreau DM, Cobb BR, Win N, McGinley MP
Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.
(2024 Aug 1)
Drug Alcohol Depend 261(): 111350
Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, Matthews AG, McCormack J, Lee AK, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Northrup TF, Braciszewski JM, Murphy MT, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Tsui JI, Burganowski RP, Weinstein ZM, Murphy SM, Hyun N, Bradley KA
Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
(2023 Dec 1)
JAMA Intern Med 183(12): 1343-1354
Wartko PD, Bobb JF, Boudreau DM, Matthews AG, McCormack J, Lee AK, Qiu H, Yu O, Hyun N, Idu AE, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Labelle CT, Zare-Mehrjerdi M, Stotts AL, Braciszewski JM, Murphy MT, Dryden D, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Phillips RC, Shea M, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Lapham GT, Addis M, Bradley KA, PROUD Trial Collaborators, Ghiroli MM, Hamilton LK, Hu Y, LaHue JS, Loree AM, Murphy SM, Northrup TF, Shmueli-Blumberg D, Silva AJ, Weinstein ZM, Wong MT, Burganowski RP
Show complete publication list

In the News

No news articles at this time.